DMAA

Drugs Made In America Acquisition Corp.
2 filings tracked
technologycloud computingMICRO (<$300M)

Signal Magnitude Chart

BULLISH | 90% | 5/14/2026 | acquisitionBULLISH | 60% | 5/14/2026 | margin expansionBEARISH | 70% | 5/14/2026 | dilution riskNEUTRAL | 40% | 5/14/2026 | capital raiseBULLISH | 90% | 5/14/2026 | acquisitionBULLISH | 60% | 5/14/2026 | margin expansionBEARISH | 70% | 5/14/2026 | dilution riskNEUTRAL | 40% | 5/14/2026 | capital raiseMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 14

Execution of a definitive merger agreement with AI-focused Power Analytics Global Corp.

acquisition
90%
bullishMay 14

G&A expenses decreased by 57% year-over-year.

margin expansion
60%
bearishMay 14

Sponsor default on subscription receivable leading to potential share cancellation.

dilution risk
70%
neutralMay 14

Secured an interim $500,000 convertible note commitment from BV Advisory Partners.

capital raise
40%
bullishMay 14

Execution of a definitive merger agreement with AI-focused Power Analytics Global Corp.

acquisition
90%
bullishMay 14

G&A expenses decreased by 57% year-over-year.

margin expansion
60%
bearishMay 14

Sponsor default on subscription receivable leading to potential share cancellation.

dilution risk
70%
neutralMay 14

Secured an interim $500,000 convertible note commitment from BV Advisory Partners.

capital raise
40%